Dozens of commonly prescribed medications can raise your triglyceride levels, sometimes significantly. The biggest offenders fall into a handful of drug classes: corticosteroids, certain blood pressure medications, antipsychotics, HIV treatments, hormone therapies, immunosuppressants, and isotretinoin (used for acne). Normal fasting triglycerides are under 150 mg/dL. Some of these drugs can push levels well above 500 mg/dL, the threshold where the risk of acute pancreatitis starts to climb.
Corticosteroids
Steroids like prednisone and hydrocortisone are among the most widely prescribed drugs that raise triglycerides. They work by ramping up the release of free fatty acids from fat tissue and boosting insulin levels, both of which feed into higher triglyceride production in the liver. The effect is dose-dependent: higher doses and longer courses cause more significant lipid changes. Short bursts for a flare-up are less likely to cause lasting problems, but people on chronic steroid therapy for conditions like lupus, asthma, or inflammatory bowel disease often see meaningful increases that persist for as long as they stay on the medication.
Beta-Blockers and Diuretics
Older, non-selective beta-blockers like propranolol can increase triglycerides by up to 50% and lower HDL (“good”) cholesterol by up to 20%. The mechanism involves blocking certain receptors that normally help clear triglyceride-rich particles from your blood. When the drug blocks those receptors unevenly, an enzyme called lipoprotein lipase becomes less active, and triglycerides accumulate instead of being broken down.
Newer, more selective beta-blockers like bisoprolol have a much smaller effect, typically raising triglycerides by no more than 20%. If you’re on a beta-blocker and your triglycerides have crept up, the specific drug you’re taking matters. Thiazide diuretics, commonly used for blood pressure, can also push triglycerides higher, though the effect is generally modest at standard doses.
Atypical Antipsychotics
Not all antipsychotics affect lipids equally. Olanzapine and clozapine consistently show the strongest association with elevated triglycerides, total cholesterol, and LDL, along with drops in HDL. Multiple studies confirm that olanzapine produces marked triglyceride increases, and clozapine has been linked to severe (though reversible) spikes. These drugs promote weight gain and alter how the body handles insulin, creating a metabolic environment that favors higher triglyceride production.
Risperidone raises triglycerides moderately, and quetiapine causes milder increases. Aripiprazole and ziprasidone stand out as having minimal or no meaningful impact on lipid levels. For people who need long-term antipsychotic treatment, this difference between individual drugs can be clinically important, and it’s worth discussing with a prescriber if lipid panels start shifting.
HIV Protease Inhibitors
HIV medications, particularly protease inhibitors, are some of the most potent triglyceride-raising drugs in clinical use. Hypertriglyceridemia occurs in roughly 28% to 50% of patients on protease inhibitor-based therapy. Ritonavir is the worst offender, increasing triglyceride levels by 100% to 300% in HIV-positive patients. Even in studies of HIV-negative subjects (where the virus itself isn’t contributing), ritonavir raised triglycerides by 146%.
Lopinavir/ritonavir combinations raise triglycerides by 27% to 108%. Nelfinavir has shown inconsistent results, with some studies finding increases of 42% to 50% and others finding none. Atazanavir and indinavir have little to no effect on triglycerides, making them better options for people already at risk for lipid problems. Nucleoside reverse transcriptase inhibitors, another class of HIV drugs, can also elevate triglycerides and cholesterol, though typically less dramatically.
Oral Estrogen and Hormonal Therapies
Oral estrogen, whether in birth control pills or hormone replacement therapy, passes through the liver before reaching the rest of the body. This “first pass” stimulates the liver to produce more triglyceride-carrying particles. The increase is usually mild in younger women on contraceptives, staying within the normal range for most. But in women who already have elevated triglycerides or a genetic tendency toward high levels, oral estrogen can tip the balance into a problematic range.
Transdermal estrogen (patches, gels) bypasses the liver entirely. Studies comparing the two routes in postmenopausal women consistently show that transdermal delivery does not raise triglycerides and may actually reduce them slightly. This makes patches or gels a better choice for women who need hormone therapy but have lipid concerns. Tamoxifen, used in breast cancer treatment, also causes mild triglyceride elevations through estrogen receptor effects in the liver.
Isotretinoin for Acne
Isotretinoin, the powerful acne drug, frequently disrupts lipid levels. It inhibits lipoprotein lipase, the same enzyme your body relies on to break down triglycerides in the bloodstream. Some estimates suggest triglyceride elevations occur in up to 50% of patients, though a study of 60 patients on low-dose therapy found hypertriglyceridemia in about 17%, with it being the most common lipid abnormality. Men in that study were somewhat more likely to develop elevated lipids (28%) than women (21%).
Because treatment courses can last up to 20 weeks, lipid monitoring is standard practice. Most guidelines recommend monthly lipid panels for the first three to six months, then every three months after that. Severe triglyceride spikes can lead to pancreatitis, so levels above 500 mg/dL during treatment typically require dose reduction or stopping the drug.
Immunosuppressants
Transplant recipients and people with autoimmune conditions often take cyclosporine, tacrolimus, or sirolimus for months or years. All three raise triglycerides through overlapping mechanisms: they increase fat production in the liver, impair insulin signaling, and reduce the body’s ability to clear lipid particles from the blood. Sirolimus may also stimulate the breakdown of fat stores in fat tissue, releasing fatty acids that the liver converts into triglycerides. Because these drugs are usually essential and can’t simply be stopped, lipid management in transplant patients often involves adding a separate lipid-lowering treatment rather than switching immunosuppressants.
Bile Acid Sequestrants
This one catches people off guard: bile acid sequestrants like cholestyramine, colestipol, and colesevelam are cholesterol-lowering drugs that can actually raise triglycerides. They work by trapping bile acids in the gut, which forces the liver to use more cholesterol to make new bile. But that same process also ramps up the liver’s production of triglyceride-rich particles. For someone whose only lipid problem is high LDL cholesterol, this trade-off may be acceptable. But if you already have elevated triglycerides, bile acid sequestrants can make the problem worse and are generally avoided.
What Drug-Induced Elevations Mean for You
If your triglycerides climbed after starting a new medication, the cause may not be dietary. Drug-induced triglyceride elevations are considered “secondary” hypertriglyceridemia, meaning they’re driven by an external factor rather than genetics or lifestyle alone. The good news is that these increases are often reversible once the medication is changed, the dose is adjusted, or a targeted treatment is added.
The degree of risk depends on how high your levels go. Mild to moderate elevation (150 to 499 mg/dL) increases cardiovascular risk over time. Severe elevation (500 mg/dL and above, especially over 1,000 mg/dL) carries the more immediate danger of pancreatitis. Genetic predisposition plays a role too: some people’s triglycerides barely budge on a given drug, while others with an underlying susceptibility see dramatic spikes on the same medication. Regular lipid monitoring is especially important when you’re on any of the drugs described above, particularly during the first few months of treatment when changes tend to emerge.